Biologic Drugs With Established Pharmaceutical Class: Programmed Death Ligand-1 Blocker
✉ Email this page to a colleague
Biologic Drugs With Established Pharmaceutical Class: Programmed Death Ligand-1 Blocker
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Emd Serono, Inc. | BAVENCIO | avelumab | Injection | 761049 | 2017-03-23 | ⤷ Sign Up | ⤷ Sign Up |
Astrazeneca Uk Ltd | IMFINZI | durvalumab | Injection | 761069 | 2017-05-01 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Patent Expiration |